Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093935 · ClinicalTrials.gov registry record · NA
StimRouter™ for Pain Management in Post-stroke Shoulder Pain
A NA study, sponsored by Bioness.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03093935 is a NA study that was terminated before completion, run by Bioness. The registered enrollment target is 6 participants.
The verdict
NCT03093935, a NA study, was terminated before completion, sponsored by Bioness.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
StimRouter Neuromodulation System includes an implanted lead which provides peripheral nerve stimulation for chronic pain. Post-stroke shoulder pain patients will be the focus of this study. After meeting inclusion/exclusion criteria, approximately 50 enrolled patients will participate in the study through 6 months of follow-up. Various measures will be used to assess patient response to use of the device.
Interventions
- DEVICE StimRouter Neuromodulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03093935
The ClinicalTrials.gov registry entry for NCT03093935 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bioness, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StimRouter Neuromodulation System is the first listed.
NCT03093935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03093935 about?
NCT03093935 is a clinical study titled "StimRouter™ for Pain Management in Post-stroke Shoulder Pain". StimRouter Neuromodulation System includes an implanted lead which provides peripheral nerve stimulation for chronic pain. Post-stroke shoulder pain patients will be the focus of this study. After meeting inclusion/exclusion criteria, approximately 50 enrolled patients will participate in the study ...
What is the current status of trial NCT03093935?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2018-07-01. Estimated completion is 2020-11-20.
What interventions are being tested in trial NCT03093935?
The interventions under investigation include: StimRouter Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT03093935?
This trial is sponsored by Bioness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.